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        In the present study, two experiments were designed to 
evaluate different protocols of (ND) and (IBD) vaccines in 
broiler and layer flocks to choose the best. 
 In both broiler and layer chicks a total of 400 one day old 
chicks 200 for each, were divided in to four groups (A, B, C and 
D). Group D in all protocols is the control. 
        In broiler and layer using different ND vaccines live and 
inactivated vaccines in four protocols and different doses (2 
doses and 3 doses) IBD D78. 
        In broiler the mean [ELAISA] titre (log2) of ND in all 
groups after 21 days post vaccination is (8.04, 11.9, 8, 5, and 
6.45) .And for IBD is (10.79, 11.41, 11.74, and 5.7).  
         In layer the mean [ELAISA] titre (log2) of ND in all 
groups after 21 days post vaccination is (12.65, 13.28, 13.1and 
4.1). And for IBD is (11.57, 10.58, 11.48, and 5.5). 
        In all groups in broiler, concluded that live ND with 
inactivated in day old and boostring with lasota in18 days is the 
best .Also 2doses D78 is better than 3 doses. 
        In layer, concluded that live ND with inactivated in day old 
and boostring with lasota or Komarov in3weeks and komarov 
with inactivated in16weeks at point of lying is the best. Also 2 
doses D78 is better than 3 doses. 
   ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﻪ
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  .ﻴﻭﻡ ﺃﻋﻁﻲ ﻨﺘﺎﺌﺞ ﺃﻓﻀل  81ﻓﻲ ﻋﻤﺭ atosal  ﻭ ﺃﺴﺘﺨﺩﺍﻡ ﺍﻟﻠﻘﺎﺡ ﺍﻟﺤﻲ 
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ﻟﻭﺤﻅ ﻓﻰ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺒﻴﺎﺽ ﺃﻥ ﺃﺴﺘﺨﺩﺍﻡ ﺍﻟﻠﻘﺎﺡ ﺍﻟﺤﻲ ﻤﻊ ﺍﻟﻤﻴﺕ ﻓﻲ ﻋﻤﺭ ﻴﻭﻡ ﻭ 
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 ﺃﻓﻀل ﻤﻥ ﺜﻼﺙ ﺠﺭﻋﺎﺕ ﻓﻲ ﻤﺭﺽ ﺠﺭﺍﺏ   78D ﻭﻜﺫﻟﻙ ﺃﻋﻁﺎﺀ ﺠﺭﻋﺘﻴﻥ ﻤﻥ





Newcastle and infectious bursal disease are major problems in poultry 
industry, and have world distribution; they are most contagious viral disease. 
ND is caused by Avian Paramyxo Virus1 and IBD caused by RNA virus. 
The morbidity and mortality ‘rates depend on the type and virulence of 
the virus strain, age, environmental condition, and reach to 100% mortality in 
susceptible chicken. The morbidity rate of IBD usually as high as 100% and 
mortality range between (10-70%). 
ND was first reported in Sudan in 1951 but isolation and identification 
of virus done in 1964, from out break in Khartoum province. IBD observed in 
late December 1980 and early January 1981. 
Vaccination is the most effective control measure of the highly 
contagious viral infections in poultry including ND and 1BD. vaccination 
programs for both diseases includes 1ive vaccines. ND virus vaccines are 
lentogenic strains (La Sota, HitchnerB1, clone 30) and mesogenic strains 
(Komarov) for secondary vaccination of birds and inactivated vaccines. IBD 
virus vaccines are live (D78, 228E) and inactivated vaccines.  
Severa1 epidemics of ND and IBD appeared in vaccinated chickens and 
caused high mortality rates. The present study was designed to find the most 
 suitable vaccination program against both viral diseases through the 
application of different vaccination programs. Another objective of this study 
is to find a relationship between imported vaccines and isolated pathogenic 
strains. 
 












 CHAPTER I 
LITERATURE REVIEW 
1. 1. Newcastle Disease  
1.1.1. Definition  
           Newcastle Disease (ND) is a major viral disease of poultry and other   
avian species (Alexander 1991). It is enzootic in most countries in Africa, 
Asia and South America (Bread and Wilkes 1985). However the disease have 
economic impact on poultry industry precipitated following outbreaks of the 
disease (Alexander and Aldous, 2001). 
 1.1.2. History 
         The disease was first described by Dolye (1926) and it was named for 
the city in England where it is catastrophic. The disease also occurred in   Java 
in Indonesia in the same year (  Dolye, 1927 ).                                                                
1.1.3. The disease in Sudan 
           ND was reported at the first time in Sudan in 1951(Anon, 1950-1951). 
The virus was first isolated in Sudan in 1964 in a natural outbreak (Karrar and 
Mustafa 1964). Twelve of the NDV strains were isolated from the country 
during 1963-1979 eight of them were velogenic and four of them were 
mesogenic (Ballouh et al, 1983). 
            According to Haroun et al. (1992) there were four NDV strains isolated 
from outbreaks around Shambat village. Moreover the local isolate of NDV 
was first characterized by Eisa (1979).The isolate was found to be virulent ND 
virus. However Khalfallah et al. (1992) reported that the most prevalent NDV 
strain in the Sudan is velogenic  viscerotropic pathotype, the strain, which 
cause heavy annual losses of the countrys poultry industry.        The lentogenic 
strain isolated for the first time in the Sudan from apparently healthy chickens 
( Khalafallah, 1994) 
1.1.4. Newcastle disease virus 
         The disease is caused by avian paramyxo virus genus Rubella virus of 
the family paramyxo viridae (Murphy et al, 1999). Furthermore the family is 
subdivided into two sub families paramyxo virinae and pneumo virinae, the 
former contains the genera Respirovirus, Rubella virus and Morbilli virus. The 
later contains the genera pneumo virus and Metapneumo virus (Murphy et al, 
1999).The genus Rubella virus consists of NDV, Avian paramyxovirus 
(2.9),canine Para influenza virus ,porcine rubella virus Michoacan Mexio 
virus, Mumps virus and human Para influenza viruses 2.4a and 4b (Murphy et 
al ,1999)  
       All isolates had  the characteristics of NV and VV strains similar to Herts 
33 Paramyxoviridae, Rhabdoviridae, Filoviridae and Bornaviridae form the 
 order Mononegavirales.all this families are enveloped, covered with 
peplomers and all have genomes consisting of asingle molecule of Negative- 
sense,single stranded RNA. (Murphy et al, 1999). 
1.1.5 Clinical signs 
     Newcastle disease virus occurs as three pathotypes Velogenic, Mesogenic 
and Lentogenic, these terms have come to be applied to high virulence, 
moderate virulence and low virulence (Alexander, 1991). Strains of NDV 
have been grouped into pathotype depending on clinical signs: viscerotropic 
velogenic is highly pathogenic form make hemorrhagic intestinal lesions, 
neurotropic velogenic form makes respiratory and nervous signs with high 
mortality mesogenic form usually occurs with respiratory signs and sometimes 
neural signs with low mortality. In lentogenic form there is mild respiratory 
signs .In asymptomatic enteric form sub clinical enteric infection and Hitchner 
form respiratory infections caused by viruses of lentogenic pathotype  (Bread 





 1.1.6. Transmission 
     ND infection takes place either by inhalation or ingestion of the virus, 
spreading depends on the availability of the virus in an infectious form 
(Alexander 1988).The important route of transmission of NDV flock is 
aerosol (Bread and Hansen, 1984). Moreover transmission by direct contact, 
air aerosol, contaminated food, water and dust particles (Murphy et al, 1999). 
Infected chicks may hatch from contaminated eggs in lentogenic strain 
(Murphy et al, 1999). 
      In natural infections, large and small droplets containing virus will be 
liberated from infected birds as result of replication of the virus in the 
respiratory tract or as result of dust and other particles including feces 
(Alexander, 1991). Some authors presented evidence that wild birds were one 
of the major factor in the spread of NDV (Khalafalla et al, l990). Vertical 
transmission doesn’t occur as there is death of infected embryos. Also newly 
hatched eggs broken eggs serve as a source of virus. 
1.1.7. Pathogenicity 
        Pathogenicity of NDV is determined by the strain of the virus, dose, route 
of administration, age and environmental condition. However, the disease is 
more acute in younger chicken and in virulent strains causes sudden death in 
young chickens without clinical signs, but older birds may be more protracted 
 and with characteristic clinical signs (Alexander, 1991b). Breed orgenetic 
constitution of the birds appears to have very little effect on the susceptibility 
of chickens to the disease (Cole and Hut, 1961). Moreover, Chickens are 
highly susceptible, but ducks and geese may be infected and show few or no 
clinical signs even with strains lethal for chickens (Higgins, 1971). 
1.1.8. Incubation period 
          Incubation period of NDV after natural exposure has been reported 2-15 
days with average 5-6 days (Alexander, 1991b). 
1.1.9. Immunosuppression 
 Immunosuppression may occur due to infection with other viruses like 
IBDV (Patlison and Allan, 1974). However Immunosuppression due to 
chicken anemia agent infection has implicated in the failure of chicken to 
respond  well second inactivated NDV vaccine (Box et al, 1989).  
1.1.10. NDV diagnosis: 
1.1.10.1. Clinical signs 
      In the visrotropic velogenic (VV) pathotype in chickens, clinical signs are 
restlessness, increase respiration, weakness prostration and death. In birds 
which do not die green diarrhea appear, muscular tremors, torticollis,  
paralysis and wing opisthotonus. Mortality reaches 100% (Alexander, 1991a) 
  The NV forms severe respiratory disease followed by neurological signs, 
dropping in egg production, morbidity is 100% ND mortality is up to 50 % 
and 90% (Alexander, 1991a).  The mesogenic NDV causes respiratory 
diseases, it may cause dropping in egg production (Alexander, 1991b).  The 
lentogenic viruses do not cause disease in adult fowl. 
1.1.10.2. Gross lesions: 
  Gross lesions depend on the strain and the pathotype of the infecting 
virus and the host (Alexander, 1991a, b). The presence of hemorrhagic lesion 
in the intestine has been used to distinguish VVND viruses from NVND 
viruses (Hanson 1980). The ovarian follicles are often flaccid and 
degenerated. Hemorrhage and discoloration of the other reproductive organs 
may occur (Alexander, 1991a). 
1.1.10.3. Virus isolation 
        Specimens for NDV isolation are taken from spleen, feces, intestinal 
contents or cloacal swabs, specimen taken from carcasses should reflect the 
clinical signs (Alexander, 1991a). Furthermore bone marrow biopsy is a useful 
sample in countries where transport is slow (Omojola and Hanson, 1986). In 
virus isolation transport the samples in frozen or chilled state is very important 
(Alexander, et al 1988). 
 1.1.10.4. Laboratory diagnosis  
1.1.10.4.1. Serological tests 
      Newcastle disease virus may be used as antigen in a wide variety of 
serological test, like Hemagglutination inhibition (HI) test or enzyme-linked 
immunosorbent assay (ELISA) to be used for diagnosis (Alexander, 1996).                  
Hemagglutination inhibition (HI) by sera of chickens that have ND or have 
been vaccinated with ND vaccines, antibodies of the sera inhibit the 
agglutination of fowl red blood cells, the antibodies appear 4-8 days after 
infection. Although HI test is simple to perform, it is different to standardize 
among laboratories (Bread and Wilkes, 1985). Other method for detecting 
antibodies is Enzyme Linked ImmunoSorbent Assays (ELISA). (Snyder et 
al. ,1983; Adair et al., 1989). Tabidi M.H et al.  2004 made a comparison 
between  the antibody (Ab) titers to the intermediate Newcastle disease virus 
(NDV) vaccine  (komarov strain) in broiler chick using haemagglutination 
inhibition (HI) test and (ELISA).for all routes of the vaccine 
administration ,higher Ab titers were detected using ELISA technique than HI 
test.                                                                                      
1.1.11. Prevention and control  
         To prevent the introduction of NDV, most countries have restriction on 
trade in poultry products, eggs and live poultry (Alexander, 1991a). The most 
 important factor in preventing the introduction of the NDV and its spread is 
prevention at the farm level during outbreaks.                                             
Proper vaccination programmes and strict biosecurity measures were proved 
in many reports as essential tools for the control of ND and IBD.(Giambrone 
and Clay,1986; Wyeth and Chettle,1990; Whitfill et al.,1995; Haddd  et al., 
1997).                                                
1.1.11.1. ND vaccines 
 ND vaccines have been used successfully since 1940 to prevent this 
disease (Bread and Hanson, 1984). According to Alexander (1999) ideal 
vaccination against ND would result in immunity against infection and 
replication of the virus.  
Commercial vaccines are live attenuated and killed vaccines. 
1.1.11.1.1. Live vaccines:  
 ND live vaccines are lentogenic and mesogenic vaccines (Plalya and 
Rwegemamu, 1991). Most live virus vaccine are grown in the allatonic cavity 
of embryonated fowl eggs but some, not ably mesogenic strains, have been 
adapted to a variety of tissue culture systems (Alexander, 2004).  
1.1.11.1.1.1 The lentogenic strain vaccines 
 These are Lasota, F (splin), Hitchner, v4 ,I2  virulent thermo stable 
strain (Alexander 1991a, Tuphuc, et al.,1998) 
 Methods of application for these vaccines are drinking water, 
intranasal , eye dropping and beak dipping (BD) (Alexander 1991a) spray and 
aerosol. 
1.1.11.1.1.2. The mesogenic strain vaccines  
 'These are Mukteswar ,Komarov (K) and Roakin , these are suitable 
only for secondary vaccination.  
1.1.11.1.2. Inactivated vaccines   
       Inactivated vaccines are produced from infective AF treated with 
betapropiolactone or formalin to kill the virus and mixed with a carrier 
adjuvant such as aluminum hydroxide or mineral oil (Cross, 1988; Alexander 
2004). Inactivated vaccines are administered by injection either 
intramuscularly or subcutaneously.inactivated vaccines are easier to store than 
live vaccines not as adversely affected by maternal immunity as live vaccines 
can be  used in day –old chicks (Box, et al.,1976).They also produce low 
levels of protective antibodies of long duration. However, their disadvantages 
are that they are expensive to produce and to apply and their quality control is 
often difficult and mineral oils may cause hazard to the vaccinator if 
accidentally injected (Stones, 1979).     
1.1.12. Routes of application                                                                     
       Methods of application of NDV vaccines are injection, eye drop, nasal 
 drop, drinking water or aerosol administration technique.  
       Drinking water is the most common means of Newcastle disease 
vaccination according to direction (Spalatin and Hanson, 1974). It has 
disadvantage, high local temperature and long time required after vaccine 
reconstitution may cause drop in vaccine titre, variation in the level of 
immunity prodused in the flock (Khair, 1992). 
       In aersol application it is important to achieve the correct size of particles   
by controlling the conditions under which the aerosol is generated 
(Meulemans, 1988) .  The aerosol method is more efficient than intranasal 
route as measured by the heamagglutination inhibition test (Khair, et, al 
1998). According to Tabidi et al., (1998) higher antibody titre was obtaind by 
aerosol than by giving the same dose via the I/N route vaccination 21 days 
later. Further more, 80% of the first group survived virulent and virus 
challenge while only 60% of the second group withstood the challenge.                                    






 1.2. Infectious Bursal Disease 
1.2.1. Definition: 
         Infectious Bursal Disease (IBD) is an acute and highly contagious viral 
infection in chicken. (Lukert and Saif, 1991). The disease was particulary 
important due to high mortalities, lowered productivity among infected 
chicks.(Shane et al, 1994). 
1.2.2. History: 
             The disease was first described by Gosgrove (1962), Winderfield et al 
(1962) isolated the virus and named it infectious bursal agent (IBA) .The 
name infectious bursal disease is termed by Hitchers (1970). 
1.2.3. The disease in Sudan: 
             IBD was first reported in the Sudan in poultry farms in 1981 in 
Elobied and it was affect chicken of 6 weeks old at that time with a mortality 
rate of 36% (Shuaib et al, 1982). In Kassala the studies of IBDV revealed that 
the virus strain was seroepidemiologically related to those strains in Elobied 
outbreak (Gaffer, et al., 1988). In 1986 in Sennar an outbreak of high 
mortality rate in 40 days old chickens (Genawi and Shuaib 1988, Genawi and 
Shuiab 1993). In 1990 the disease occurred in south east of Khartoum. The 
data presented in this outbreak revealed that a low virulent strain of IBDV is 
present among broiler chicks in the Sudan (Khalafalla et al 1990-1991). 
 Serological detection of IBD antibodies among non vaccinated, non- 
previously infected flocks confirms the existence of sub clinical IBD in the 
Sudan (Mahasin, 1998). 
1.2.4. IBDV:  
        Infectious bursal disease virus (IBDV) is a member of the family Birna 
viride (Dobos et al, 1979). In the family three genera Avibirna virus,Aquibirna 
virus and Entombirna virus ,IBDV is a member of genus Avibirna virus. 
      The virus is resistant to many disinfectant and environmental factor for at 
least 4month in poultry house (Gary et al., 2000). IBDV Verions are non-
enveloped, hexagonal in outline with icosahhedral symmetry, 60nm in 
diameter. The genome consists of two molecules of liner double stranded 
RNA (Murphy et al., 1999). The larger segment encodes three proteins 
namely vp2, vp3 and vp4; of which vp2 and vp3 are structural proteins while 
vp4 is viral protease .the smaller segment encodes viral protein (vp1) 98,000 
dalton and the viral polymerase (Fhey et al., 1991) 
1.2.5. Serotypes and Varient:                         
             Mc ferran et al (1980) in European origin and Jack wood et al in USA 
(1982) presented that evidence for the presence of two serotypes  designated 1 
and 2 .The two serotypes are differentiated by virus neutralization test 
VNT ,although they show a common antigen (Saif,1994).  Serotype1viruses 
 are only pathogenic for chicken, serotype 2 viruses infect chicken and turkey 
but these infections are of unknown clinical significant (Ismial, et al., 
1988) .Immunization against serotype2 doesn't protect against sertype1 and 
antibodies to serotype2 are common in both chickens and turkey (Jack wood 
and Saif, 1983).  
 1.2.6. Pathogenesis of IBDV: 
       Infectious bursal disease is the selective replication of virus in the bursa 
of fabricius, which in early infections becomes enlarged up to five times its 
normal size and becomes edematous, hyperemic and cream colonial with 
prominent longitudinal lymphoid follicles of the bursa become necrotic 
(Murhy et al., 1999). A virulence forms of the virus produce depletion of cells 
in the thymus, spleen and bone marrow (Alan et al., 1972; Earagler et al., 
1974). 
         IBDV affects lymphoid tissue causing destruction of the bursa derived 
lymphocytes within the bursa of fabricius, in the thymus, spleen and caecal 
tonsils. Thymus derived lymphocytes are relatively unaffected (Jorden, et al., 
1990). 
1.2.7. Transmission 
         The virus is resistant to heat and disinfectants, which make it, survive 
the adverse environmental condition: infected litter is infectious even after 
 seven weeks (Brar and Robinson, 1999). Equipment and people can transmit 
IBDV among farms (Butcher and Miles, 1999). 
1.2.8. Immunity to IBVD 
          Birds that are recovered from IBDV infection or vaccination showed 
serum-neutralizing activity homologous and heterologus IBDV strains when 
assayed in chick embryos (Winterfield, 1969). Chicks exposed to IBVD at age 
of three weeks did not develop as high neutralizing titer as those exposed four 
weeks later (Winterfield, 1969). Carmen (1994) reported that vaccines of low 
virulence break down the MDA in the forth week of life. However maternal 
immunity is able to protect the chicks against the disease but can neutralize 
the vaccine virus (Vob and Vielitz, 1994; Zaheer and Saeed, 2003). 
1.2.9. Immunosuppression 
    Dohm and Saif (1984) defined immunosupression as astate of temporary  or 
permanent dysfunction of the immune response  resulting from damage to the 
immune system and leading to increased susceptibility to disease and always 
leading to sub-optimal antibody response (Lutticken 1997). 
        Immunosuppressive effect of infectious bursal disease virus on 
vaccination against Newcastle disease was compared two, three and four 
weeks old chickens inoculated with the highly virulent IBDV field isolate 90-
11 and the reference serotype 1 strain GBF-1. In all ages groups, isolate 90-11 
 severally suppressed antibody response to Newcastle vaccination and 
protective vaccine immunity against Newcastle. 
           The mesogenic response to phytohemagglutinin of splenic lymphocytes 
from chicken inoculated with isolate 90-11 or strain GBF-1was significantly 
lower than an inoculated control (Nokamura and Nunoya, 1992). IBD of 
chickens and hemorrhagic enteritis in broiler were diseases that induced 
immunosuppression, resulting in lowered resistance to a variety of infectious 
agents and poor response to commonly used vaccines (Saif, 1998). 
1.2.10. Clinical signs 
            The signs of the disease are soiled vent feathers, ruffled feathers, 
watery diarrhea, anorexia, depression, dehydration and finally death 
(Gosgrove, 1962). 
1.2.11. Lesions 
1.2.11.1. Macroscopic lesions 
            Bursa of fabricius is the target organ for IBDV lesions (Kâufer and 
Weiss, 1980). It appears in the bursa before clinical signs. Gross lesion 
induced dehydration with darkened discoloration of pectoral muscles, 
intestinal mucous and renal changes (Gosgrove, 1962). 
1.2.11.2. Microscopic lesions  
             They occur primarily in the lymphoid structures cloacal bursa, spleen, 
 thymus, harderian gland and caecal tonsils. Histological evidence of infection 
in the cloacal bursa within 24 hours (Helmloldt and Garner, 1964).   
Degeneration and necrosis of lymphocytes in the medullar area of the bursal 
follicle appears early: one day after infection. Lymphocytes are replaced by 
heterophilli, pyknotic debris and hyperplastic reticuloendothelical cells 
(Lurket and Saif, 1991). The spleen showed hyperplasia of reticuloendothelial 
cells in early stage then lymphoid necrosis in the germinal follicles (Lurket 
and Saif, 1991). 
1.2.12. Diagnosis 
               The disease can be diagnosed by clinical signs and postmortem 
changes. However in practice, laboratory diagnosis of IBD depends on 
detection of specific antibodies to the virus, using immunological methods. 
Identification of the virus by direct immunoflurescent staining or direct 
examination by electron microscopy (McFerran et al., 1980). A direct 
immunoflourescent smear of bursa of fabricius and direct electron microscopy 
examination are more sensitive method than virus isolation and direct electron 
microscopy (Allan, et al.,1994). Agar gel diffusion test (AGID) is the most 
useful for detection of specific antibodies in serum or urinal antigen in bursal 
tissue and the test can be used to measure antibody levels (Cullen and Wyeth, 
1975). AGIDT is economic to use and simple to perform and the result could 
 be obtained within 28 hours. Virus neutralization test (VNT) is more laborious 
and expensive than AGID, but is more sensitive in detecting antibodies, so it 
may be useful for evaluating vaccines responser or differentiate between the 
two serotypes (Isamil and Saif, 1990). Enzyme linked Immunosorbant assay 
(ELISA) was firstly developed for detection of IBDV antibodies (Marquard et 
al 1980). Antigen capture (AC) The ELISA had been used for detection of 
IBDV antigens directly from infected tissues (Synder et al, 1988). It was for 
serosurveyes of chicken flock (Synder et al 1986). The ELISA is the most 
rapid test and its results are easily entered into computer software. The reverse 
transcriptase polymerase chain reaction restriction endonuclease. (RT \ PCR –
RE) assay can be used to diagnose IBD in chickens and IBDV strains 
(Jakwood and Nilsen, 1997). 
1.2.13. Prevention and control 
The control of the disease depends on vaccination and management. 
1.2.13.1. Vaccination: 
In 1970, only live vaccines were used to control IBD. Large variation in 
the degree of the attenuation of vaccines strains and the effects of 
heterogeneous level of maternal antibodies (which effect the suitable time to 
vaccinate) make many problems at that time (Myth, 1980). Maternal 
antibodies protect chicks for 1-3 weeks, but by boostering with oil adjuvant 
 vaccine, the immunity may extend to four or five weeks (Lucio and Hichner, 
1979). Progeny can be protected by vaccinating the parent stock, thereby 
providing passive immunity, or young birds can be immunized by vaccinating 
with live IBD vaccine (O`Brien, 1976). Recently, technology has been 
developed to deliver live vaccine into eggs during the incubation period. Live 
vaccine virus is blended with IBD antibody and the complex is injected in ovo 
at 18 days of incubation. The eggs on to hatch and the vaccine virus are 
released when the chicks are about 7 days of age. In this way, the problem of 
maternally derived IBD antibody is overcome and the chicks are effectively 
immunized (OIE, 2000).  The IBDV vaccine strains used to control the disease 
worldwide and classified as mild, intermediate and hot strains based on their 
capability to neutralize the MDA and cause. 
  Types of vaccines:  
These are live attenuated vaccines and inactivated oil emulsion adjuvant 
vaccines. 
1.2.13.1.1. Live vaccines 
Live vaccines strains can be categorized into three groups according to 
the test bursal body weight ratios (Michele Guittet et al. 1994). 
 
 1.2.13.1.1.1. Mild strains 
It is susceptible to the effect of maternally derived antibody (MDA), so 
should be administrated only after all MDA has wanted. Application is by 
means of intramuscular injection, spray or drinking water at 8 weeks age 
(Skeals et al. 1979). 
1.2.13.1.1.2. Intermediate strains 
                  Intermediate vaccines are used in young parent chicken if there is a 
high risk of natural infection with virulent IBD. They are some times 
administrated at one day old as a course spray to protect chicken in the flock 
that may have no or only minimal level of MDA (OIE, 2000). Second and 
third doses are usually administrated, especially when there is a high risk of 
exposure to virulent forms of the disease (OIE, 2000). Feed based IBDV 
vaccination was recently tried with good result (Hair-Bejo et al. 2004). 
1.2.13.1.1.3. Hot strain 
Hot strain is used in severe affected areas such as intervet Lz 228E and 
TADLC75. It`s used should be where no other means of control exist (Löhern, 
1994).          
1.2.14. Inactivated vaccine 
Inactivated vaccines produce high, long, lasting and uniform levels of 
antibodies in breeding hens that have previously been primed by live vaccine 




















 CHAPTER II 
MATERIALS AND METHODS 
2.1. Chicks: 
                 Two hundred chicks of male (Bovan Hybrid) and two hundred 
chicks of broiler (Ross 308) were used in the study from Coral Poultry 
Company. 
2.2. Vaccines: 
2.2.1. Clone 30: 
                 This is Nobilis ND clone 30 is a line, freeze-dried vaccine against 
ND. Each dose contains at least 106 ELD50 of the ND strain clone 30. The 
vaccine pellet contains stabilizers and Gentamicin. 
2.2.2. ND Broiler: 
                  Inactivated vaccine for the protection of day old chickens against 
ND. Nobilis MD Broiler contains one immunogenic strain of NDV. The virus 
has been grown on embryonated eggs and is inactivated with formalin, 
subsequently they have been suspended in the aqueous phase of an oil 
adjuvant emulsion. 
2.2.3. Nobilis MA5+clone 30: 
This is an alive, freeze-dried vaccine against IB and ND. Each dose 
contains at least 103 EID50 IBV strain MA5 and 106 EID50 NDV strain clone30. 
 2.2.4. La Sota: 
It is a live NDV vaccine containing the lentogenic chick embryo 
propagated, Lasota strain of the virus. 
2.2.5. Komarov: 
It is a freeze-dried, live chick embryo adapted vaccine containing 
Komarov strain, supplied by the viral vaccine unit centre of Veterinary 
Research Laboratories. 
2.2.6. Gumboro D78: 
Nobilis Gumboro D78 is an alive, freeze-dried vaccine. Each dose 
contains at least 4.0 log10 TCID50 of the Gumboro strain D78. The vaccine 
pellet contains stabilizer and Gentamicin. 
2.2.7. Nobilis IB +ND: 
This is a combined inactivated vaccine for the protection of the 
chickens against Avian Infectious Bronchitis (IB) and Newcastle disease 
(ND). It contains one immunogenic strain of IBV, one immunogenic strain of 
NDV, grown on embryonated eggs or Vero cell culture and inactivated with 
formalin subsequently they have been suspended in the aqueous phase of an 
oil adjuvant emulsion. 
2.3. Vaccination pogramme: 
All chicks were divided into four groups namely A, B, C and D (50 per 
 group). Chicks in all groups were bled by head puncture method after one day 
old and the collected blood left overnight at room temperature to clot and then 
centrifuged at 1000 rpm for 10 minutes. Separated sera were store at -20ºC 
before tested for antibodies level for ND and IBD in 1day old using ELISA. 
2.3.1. Experiment 1: 
Chicks in group A were vaccinated at a day old with clone 30 via the 
aerosol and ND Broiler injection. Then, in thirteen days old, they were 
vaccinated with D78, the second dose in 20 days and the third dose in 27 days 
in drinking water. Chicks in group B were vaccinated at a day old with 
MA5+clone 30+ND Broiler injection, in 13 days old vaccinated with D78 and 
the second dose in 20 days in drinking water. Then in 23 day, they were given 
Lasota in DW. Chicks in group C were vaccinated at day old with clone 30 via 
the aerosol and 13 day and 20 day with D78 in DW. Then, with Komarov in 23 
day. Chicks in Group D was left without vaccination as control. 
Chicks in all groups were bled by wing puncture method after 21 days 
and the collected blood left overnight at room temperature to clot and then 
centrifuged at 1000 rpm for 10 minutes. Separated sera were store at -20ºC 
before tested for antibodies level for ND and IBD in 48 days using ELISA. 
 2.3.2. Experiment 2: 
Chicks in group A were vaccinated at day old with clone 3 via the 
aerosol and ND Broiler injection. Then, in 24 day they were vaccinated with 
D78, second dose in 31 days, third dose in 38 days in drinking water and 
finally with Komarov in 58 days. Chicks in group B were vaccinated at day 
old with MA5+clone 30 (spray) +ND Broiler (injection). Then, they were 
vaccinated with Lasota (DW) in 21 days. In 24 days, 31 days, and 38 days 
they were vaccinated with D78 (DW) and with Lasota again in 58 days. Chicks 
in group C were vaccinated in day old with clone 30 (spray). In 21 days, they 
were vaccinated with Komarov, in 24 days with D78 (DW) and in 58 days with 
Komarov. Chicks in groups A, B and C were vaccinated in 16 weeks with 
inactivated IB+ ND (injection). Then, a day after they were vaccinated with 
Komarov (intranasal) and after another week, they were vaccinated with live 
IB (DW). Chicks in group D were left as control. Chicks in all groups were 
bled and separated sera were used for measuring antibodies level for ND and 
IBD 48 days using ELISA and in 19 weeks for antibodies level for ND and IB 




 2.4. ELISA for IBD and ND disease: 
2.4.1 Reagents provided: 
2.4.1.1 NDV and IBD coated plates: 
Inactivated viral antigen on microtitre wells, 
2.4.1.2, Conjugate reagent: 
Sheep anti-chicken: alkaline phosphates in tris buffer with proteir 
stabilizers, inert red dye and sodium azide preservative (0.1 % w/v). 
2.4.1.3. Substrate buffer: 
Diethanolamine buffer with enzyme cofactors. 
2.4.1.4. Substrate Tablets  
pNPP(p-Nitrophenyle phosphotase) tablets to be dissolved with 
Substrate buffer.  
2.4.1.5. Stop solution: 
Sodium Hydroxide in Diethanolamine buffer. 
2.4.1.6. Sample diluent: 
Phosphate buffer with protein stabilizers, inert green dye and sodium 
azide preservative (0.1 % w/v). 
2.4.1.7. Wash buffer: 
Powdered phosphate buffered saline with Tween. 
2.4.1.8. Negative control: 
 Specific pathogen free serum in phosphate buffer with protein 
stabilisers and sodium azide preservative (0.1 % w/v). 
2.4.1.9, Positive control: 
Antibodies specific to NDV and IBDV in Phosphate buffer with protein 
stabilisers and sodium azide preservative (0.1% w/v). 
2.4.2 Materials and equipment required: 
Precision Pipettes and disposable tips, eight or twelve channel 
pipette/repeater pipette. Plastic tubes for sample, distilled or  deionized water, 
microtiter plate reader with 405nm filter, microtiter plate washer. 
2.4.3 Reagent preparation: 
2.4.3.1. Substrate reagent: 
I tablet was added to 5.5 of substrate buffer and allowed to be mixed for 
3 minutes or until fully dissolved. The prepared reagent was made on the day 
of use, it was stable for one week when kept in the dark at + 4ºC. Tablets were 
dropped into clean container and appropriate volume of substrate buffer .was 
added. 
2.4.3.2. Wash buffer: 
The contents of wash buffer sachet were dissolved in one litre of 
distilled/deionized water. It remained stable for up to one month when stored 
in + 4ºC. All other kit components are ready to use, they were allowed to 
 come to room temperature before use. 
2.4.3.3. Sample preparation: 
Test sample was diluted 1:500 by adding 1 µl to 0.5ml of sample 
diluent. Well was mixed with vortexing. A fresh pipette was used for each 
separate sample. The dilution tube was clearly identified with sample number. 
Positive and negative controls do not require diluting. 
2.4.3.4. Test procedure: 
NDV or IBDV coated plates were removed from sealed bag and the 
location of sample was recorded on template. 100 µl of negative control was 
added into wells Cl and Dl. Then diluted samples were added into appropriate 
wells and the plate was covered with lid and incubated at room temperature 
(22- 27ºC) for30 minutes. The contents of wells were aspirated and the plate 
was washed four times with wash buffer, inverted and tapped firmly on 
absorbent paper. 100 µl of conjugate reagent was added to each well, and the 
plate was covered with lid and incubated at room temperature for 30 minutes. 
The wash procedure was repeated, 100 µl of prepared substrate reagent was 
added to each well and the plate was covered with lid and incubated at room 
temperature for 15 minutes. 100 µl of stop solution was added. The microtitre 
plate was blanked in air and the reading was recorded by reading at 405nm. 
 2.5. Data analysis: 
Coefficient of Variation (CV): is an indicator of individual value dispersal 
with regards to titer mean. 
Coefficient of Variation =  standard deviation  
     Arithmetic mean titer 
CV values is currently made according to the following threshold 
 < to 30% = Very homogenous   30 to 50% = Homogenous  
 50 to 80% = poorly homogenous > 80% = Heterogeneous 














 CHAPTER III 
Results 
3.1. Experiment 1 ـــ Broiler flock 
3.1.1. Mean antibody titre (log 2) for ND in broiler chicks 
           Figure 1 in experiment 1 shows mean antibody titre (log2 titre) for ND 
of 4 different protocol (A, B, C and D) pre and post vaccination after 21 days 
from the last dose by ELISA.  
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 3.1.2. Mean antibody titre (log 2) for IBD in broiler flock 
          Figure 3 in experiment 1 shows mean antibody titre ( log 2 titre ) for 
IBD 1 of 4 different protocol A, B, C and D pre and post vaccination after 21 
days from the last dose by ELISA. 
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Table 1: the coefficient variation of ND MDA in Broiler Chicks 
vaccinated via different protocol in groups (A, B, C and D):  
Days  Group A Group B Group C Group D 
2 days old 52 52 52 52 




Table 2: the coefficient variation of IBD MDA in Broiler Chicks 
vaccinated via different protocol in groups (A, B, C and D):  
Days  Group A Group B Group C Group D 
2 days old 67 67 67 67 
48 days old 77 42 46 50 
 
< to 30% = Very homogenous   30 to 50% = Heterogeneous 
50 to 80% = poorly homogenous > 80% = Heterogeneous 




 3.2. EXPERMENT 2 ـــ Layer flock  
3.2.1. Mean antibody titre (log 2) for ND in Layer flock 
          Figure 5 in experiment 2 shows mean antibody titre (log 2 titre) for ND2 
of 4 different protocol (A, B, C and D) pre and post vaccination after 21 days 
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3.2.4. Mean antibody titre (log 2) for IBD2 in Layer flock 
          Figure 8 in experiment 2 shows mean antibody titre (log 2 titre) for 
IBD2 of 4 different protocol (A, B, C and D) pre and post vaccination after 21 
days from the last dose by ELISA. 
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 Table 3: the coefficient variation of ND MDA in Layer Chicken 
vaccinated via different protocol in groups (A, B, C and D):  
Days  Group A Group B Group C Group D 
2 days old 75 75 75 75 
48 days old 82 90 200 224 
133 days old 62 62 54 128 
 
 
Table 4: the coefficient variation of IBD MDA in Layer Chicken 
vaccinated via different protocol in groups (A, B, C and D):  
Days  Group A Group B Group C Group D 
2 days old 62 62 62 62 
62 days old 43 70 48 44 
 
< to 30% = Very homogenous   30 to 50% = Heterogeneous 
 50 to 80% = poorly homogenous > 80% = Heterogeneous 





 CHAPTER IV 
Discussion  
 
 Newcastle disease and infectious bursal disease are important diseases 
in poultry industry in Sudan, to control these diseases many vaccines had been 
introduce. 
 The proper time of vaccination, varies and depends on maternal derived 
antibodies (Ab), route of vaccination, virulence of the vaccine strain, 
environmental stresses and management are essential factors to be considered 
when developing a vaccination program. 
 In this study we followed very important  steps to choose a perfect 
protocol, firstly measuring MDA for ND and IBD to choose the suitable time 
to vaccinate  this is agree with Lurket and Saif (1991) who reported that  
monitoring of antibody level in the Flock com aci kin determine the proper 
time to vaccinate . Then, using  ELISA technique to  measuring Ab titre  
according to Tabbidi et al (2004) who mentioned that for all routes of the 
vaccine administration ,higher Ab titers were detected using ELISA technique 
than HI test. 
 
 The satisfactory levels of immunity are not reached after vaccination of 
maternally immune chicks unless vaccination is delayed until the 2-3 weeks of 
life (Allan, 1971).So in this study the blood sample was taken in 3weeks after 
vaccination to measuring Ab titre after vaccination   
 In ND vaccine mesogenic strians are used as booster dose because the 
mild live vaccines do not multiply very efficiently when used as boosters in 
face pre of existing immunity and hence the secondary response that they 
induce is rarely very much high than the primary response vaccination of 
young chicken which have high level of MDA was considered as on of the 
main problems associated with control of ND (Dawson and Allan, 1973)  
             The effect of MDA the immune response against ND vaccination was 
well documented (Mahasin et al, 1980; Haroun and Hajer, 1989). 
 In the present study, using different vaccines for ND, using live 
vaccines only and live with in activated vaccines to compare. For IBD we 
used intermediate strain D78 two doses and three doses to compare. In all 
protocols in this study ND vaccine was administrated before IBD vaccine. 
            Solano and et al, 1989 confirmed that high level of MDA protect the 
chicks from infection by IBDV in early ages. In this study we used D78 in 2 
weeks in broiler chicks and after 3 weeks in layer chicken.   
 
               MDA was found to reduce the level of protection produced by 
vaccination .MDA may not always be protective against natural infection in 
moderate to high titer (Allan, 1973). 
In experiment 1 the broiler chicks was vaccinated with ND clone 30 
(spray) at one old with inactivated (ND Broiler) vaccine I\M  and boostring 
dose with La Sota vaccine (DW)  at 20 days showed high Ab titer than using 
live only with boostring dose with kamorov vaccine. And vaccinated two 
doses IBD D78 vaccine showed high antilogy level than 3 doses.  
In IBD vaccination (Iurket and Saif 1991) (MDA) maternal derived 
antibodies men front in sufficient to protect broiler chicks against highly 
pathogenic strain of IBDV during the growth period Evan the patient flock 
had been boostred at pointed lay using oil emulsion vainer (OIE) (Van Den 
Berg et al ,1991).  
Regeswar and Masillamony (1993) mentioned that vaccinated with la 
Sota or B1 by aresol at 7 days of age could be given with dose level low than 
the usual dose and at early age without side effect and good immunity. The 
efficacy of Komarov vaccine might improve if the filed dose increased (Ali, 
1973). K vaccine was recommended to be given by I\N in 4 weeks and 
repeated at point of lying. (Ali, 1978). 
 
 In Experiment (2) layer Flock using Live (clone 30) spray in day old 
with inactivated (NDBroiler) I\M and La Sota (DW) or Komarov 1/N at 3 
weeks and in 58 day showed the highest antilogy level.  In 16week using 
Komarov 1/N with in activated (IB + ND) I\M showed high antibody titre in 
all groups , also using 2 doses D78 showed high antilogy level than 3 doses 
 According to Khair 1992,vaccinated chicken at 4 weeks of age by 
Komarov strain 1/N route gave immune response greater than given vaccine 
by DW route. Vaccinated 18day old broiler chickens onse with Komarov1/N 
or1/M route had high antibody titres than DW route (Gaffer Elamin et al, 
1993). 
In conclusion, this study revealed that  in broiler chicks vaccinated with 
clone 30 (spray) at a day old with inactivated (ND Broiler) I\M  and boostring 
with La Sota (DW)  at 20 days showed the highest Ab titer. And vaccinated 
with two doses IBD D78 showed high antilogy level. In layer Flock using Live 
(clone 30) spray in day old with inactivated (NDBroiler) I\M and La Sota 
(DW) or Komarov 1/N at 3 weeks and in 58 day showed the highest antilogy 
level.  In 16week using Komarov 1/N with in activated (IB + ND) I\M showed 
high antibody titre in all groups, also using 2 doses D78 showed high antilogy 
level. 
 
 Therefore it is recommended for ND to use live vaccines with the 
inactivated vaccines, special in layers, for IBD using 2 doses D78 after 
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